Harvard Bioscience (HBIO) Competitor Comparison
We are evaluating the key criteria listed to compare Harvard Bioscience (HBIO) against its competitors in the Medical Instruments & Supplies industry.
Market Capitalization
34 / 44Gross Profits
29 / 40Total Revenue
31 / 43EBITDA
25 / 44Free Cashflow
26 / 44Quick Ratio
41 / 44Earnings per Share
24 / 44Dividend yield
0 / 13Total Cash
40 / 44Performance 3 years
34 / 44Performance 5 years
20 / 44Performance 10 years
32 / 44Linearity 3 years
28 / 44Linearity 5 years
9 / 44Linearity 10 years
11 / 44Total Rank
36 / 44Dividend Rank
42 / 44Valuation Rank
30 / 44Piotroski Rank
38 / 44Muliplier Rank
41 / 44Gross Profits - HBIO ranking 29 / 40
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.